Riskpilot← Back to searchSign inGet full accessIBUS INNOVATION A/S
A/SActiveCVR 29769699Odinshøjvej 116Research and experimental development on natural sciences and engineering · NACE 7210Est. 20061 employees
Revenue 2025
DKK -37K
-274% vs 2024
EBITDA margin
270.5%
+5% vs 2024
Equity ratio
-629.6%
Financial strength
Net profit 2025
DKK -125K
+81% vs 2024
| Revenue | DKK -37K | -274% |
| EBITDA | DKK -100K | +5% |
| Net profit | DKK -125K | +81% |
| Total assets | DKK 187K | +2% |
| Equity | DKK -1,2M | -12% |
| Employees | 1 | — |
Legal name
IBUS INNOVATION A/S
CVR number
29769699
Legal form
Aktieselskab
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
4. august 2006
Share capital
DKK 502.000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør alene. Selskabet kan desuden tegnes af den samlede bestyrelse.
Company purpose
Selskabets formål er at drive virksomhed med handel, industri, håndværk og finansiering og anden i forbindelse hermed beslægtet virksomhed
Address
Odinshøjvej 116
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | -375 | -172 | -38 | 21 | -37 |
| Staff expenses | -193 | -150 | -126 | -126 | -63 |
| EBITDA | -568 | -322 | -164 | -105 | -100 |
| Depreciation & amort. | -5.004 | -1.504 | -80 | -560 | -0 |
| EBIT | -5.572 | -1.826 | -244 | -665 | -100 |
| Net financials | -173 | -20 | -20 | -22 | -26 |
| Profit before tax | -5.745 | -1.845 | -264 | -687 | -125 |
| Tax | -220 | -41 | -29 | -29 | -0 |
| Net profit | -5.526 | -1.804 | -235 | -658 | -125 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 2.810 | 785 | 692 | 183 | 187 |
| Equity | 1.644 | -160 | -395 | -1.053 | -1.178 |
| Long-term debt | 622 | 840 | 1.053 | 1.198 | 1.345 |
| Short-term debt | 543 | 105 | 34 | 37 | 20 |
| Total debt | 1.165 | 945 | 1.087 | 1.235 | 1.365 |
EBITDA margin
-9970800.0%
This company
15.8%
Market median
-63106429% vs market
20212025
Equity ratio
-629.6%
This company
38.2%
Market median
-1748% vs market
20212025
Return on equity
-12537300.0%
This company
18.4%
Market median
-68137600% vs market
20212025
Net profit margin
-12537300.0%
This company
8.1%
Market median
-154781581% vs market
20212025
Asset turnover
-0.20×
This company
1.12×
Market median
-118% vs market
20212025
Debt / equity
1.16×
This company
0.62×
Market median
-87% vs market
20212025
- Annual report 2025Filed via CVR / Virk · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via CVR / Virk · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via CVR / Virk · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via CVR / Virk · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via CVR / Virk · Period 2020-07-01 – 2021-06-30
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
LH Chief Executive Officer | Chief Executive Officer | 2007 |
| Former (1) | ||
BH Chief Executive Officer | Chief Executive Officer | 2006 – 2007 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2006 | |
| Board of Directors | 2020 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2006 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
HOLM CHRISTENSEN BIOSYSTEMER ApS
IBUS INNOVATION A/S Board members of IBUS INNOVATION A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Børge Holm Christensen | Chief Executive Officer | 0 companies |
| Lena Holm Christensen | Chief Executive Officer | 0 companies |
| Birgitte Holm Christensen | Board of Directors | 0 companies |
| Inger Lise Christensen | Board of Directors | 0 companies |